CEO, Mary Fisher, has been honored with the 2013 EY Venture Capital Award of Excellence. Now in its eighth year, the Venture Capital Award of Excellence winners are selected from those EY Entrepreneur Of The Year regional winners whose companies have been backed by venture capital funding.
The awards program recognizes outstanding high-growth entrepreneurs from companies who have received venture capital backing and who demonstrate excellence and extraordinary success in such areas as innovation, financial performance and personal commitment to their businesses and communities.
The award recipients were selected by a panel of independent judges and were honored at an awards dinner at the 2013 EY Strategic Growth Forum on Wednesday, November 13, 2013.
"I am truly honored, and believe this award is the culmination of a successful team effort," said Ms. Fisher.
During her tenure with SkinMedica, Ms. Fisher led dynamic year-over-year growth. Then under Fisher's purview, SkinMedica sold their medical assets to Intendis, a division of Bayer in 2009, rolled out a first of its kind customer educational initiative along with a sales force expansion in 2010, acquired Colorescience in 2011, and was a key player in SkinMedica's acquisition by Allergan in December 2012.
Since joining Colorescience in April of this year, Ms. Fisher bolstered the brand's executive team, which together has mapped out their plans for accelerated growth, and subsequently raised $10 million in Series A Venture Capital Financing.